Combining Causal and Correlative Approaches to Discover Response Biomarkers to Paclitaxel
February 21, 2024
The discovery of predictive biomarkers to paclitaxel vulnerability [such] as SSR3 [signal sequence receptor 3] promises to significantly impact cancer treatment.”BUFFALO, NY- February 21, 2024 – A new research perspective... read more